BMO Capital Maintains Outperform on Aveanna Healthcare Hldgs, Raises Price Target to $14

Benzinga · 1d ago
BMO Capital analyst Sean Dodge maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Outperform and raises the price target from $10 to $14.